All In Biotech

Drug Trial Radar · NCT05002127

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

A Phase 2/3 Study of Evorpacept (ALX148) in Patients With Advanced HER2-Overexpressing Gastric/Gastroesophageal Junction Adenocarcinoma (ASPEN-06)

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 127 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

127

Actual

Start

Jan 15, 2022

Primary completion

May 24, 2024

Study completion Jun 30, 2026

Sponsor

Lead sponsor
ALX Oncology Inc.Industry
Sponsor type
Industry
Collaborators
Eli Lilly and Company
First posted
Aug 12, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2/3 Study of Evorpacept (ALX148) in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Patients With Advanced HER2-overexpressing gastric/GEJ adenocarcinoma.

Conditions

  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Gastric Adenocarcinoma

Interventions

  • Evorpacept (ALX148)Drug

    IV Q2W

  • TrastuzumabDrug

    IV Q2W

  • RamucirumabDrug

    IV Q2W

  • PaclitaxelDrug

    IV Days 1, 8, and 15 of a 28-day cycle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 2Time frame: Last randomized patient on study at least 16 weeks
  2. Phase 3Time frame: From the date of randomization to the date of death (due to any cause), up to 36 months postdose

Locations

83 sites in 12 countries. Site status is shown where the registry gives one.

  • The Oncology Institute of Hope & Innovation

    Anaheim, California

  • University of California Los Angeles

    Los Angeles, California

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • NEXT Virginia

    Fairfax, Virginia

  • Fred Hutchinson Cancer Center

    Seattle, Washington

  • Icon Cancer Centre Southport

    Southport, Queensland, Australia

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • Universitair Ziekenhuis Antwerpen

    Antwerp, Belgium

  • Universitair Ziekenhuis Leuven - Campus Gasthuisberg

    Leuven, Belgium

  • Centre Hospitalier Universitaire de Liège

    Liège, Belgium

  • Fakultní Nemocnice Hradec Králové

    Hradec Králové, Czechia

  • Fakultní Nemocnice Olomouc

    Olomouc, Czechia

  • Vseobecna Fakultni Nemocnice v Praze

    Prague, Czechia

  • Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz

    Besançon, France

  • Centre Hospitalier Universitaire de Bordeaux

    Bordeaux, France

  • Hôpital Morvan

    Brest, France

  • Centre Léon Bérard

    Lyon, France

  • Hôpital Privé Jean Mermoz

    Lyon, France

  • Institut Paoli-Calmettes

    Marseille, France

  • Hôpital Saint-Antoine

    Paris, France

  • Hôpital Trousseau

    Paris, France

  • Hôpital Rangueil

    Toulouse, France

  • Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi

    Catania, Italy

  • Azienda Ospedaliero - Universitaria Careggi

    Florence, Italy

  • Fondazione IRCCS - Istituto Nazionale dei Tumori

    Milan, Italy

  • Policlinico Universitario Campus Bio-Medico

    Roma, Italy

  • Azienda Sanitaria Universitaria Friuli Centrale - P.O. Santa Maria della Misericordia

    Udine, Italy

  • National Cancer Center Hospital East

    Chiba, Japan

  • Kyushu Cancer Center

    Fukuoka, Japan

  • Gifu University Hospital

    Gifu, Japan

  • Japanese Red Cross Kumamoto Hospital

    Kumamoto, Japan

  • University Hospital Kyoto Prefectural University of Medicine

    Kyoto, Japan

  • Nagasaki University Hospital

    Nagasaki, Japan

  • Oita University Hospital - Hasama Campus

    Ōita, Japan

  • Osaka Prefectural Hospital Organization - Osaka International Cancer Institute

    Osaka, Japan

  • Kindai University Hospital

    Osaka, Japan

  • Saitama Cancer Center

    Saitama, Japan

  • Tohoku University Hospital

    Sendai, Japan

  • Shizuoka Cancer Center

    Shizuoka, Japan

  • National Cancer Center Hospital

    Tokyo, Japan

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.